Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours

被引：0
|
作者：
Roberto, M. [1 ]
Arrivi, G. [2 ]
Milano, A. [1 ]
D'Antonio, C. [1 ]
Romiti, A. [3 ]
Falcone, R. [1 ]
Mazzuca, F. [1 ]
Fais, S. [4 ]
Marchetti, P. [1 ]
机构：
[1] Univ Roma La Sapienza, St Andrea Hosp, Rome, Italy
[2] St Andrea Hosp, Rome, Italy
[3] Univ Roma La Sapienza, St Andrea Hosp, Oncol Dept, Rome, Italy
[4] Ist Super Sanita, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 160
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial
    Marchetti, Paolo
    Milano, Annalisa
    D'Antonio, Chiara
    Romiti, Adriana
    Falcone, Rosa
    Roberto, Michela
    Fais, Stefano
    CLINICAL COLORECTAL CANCER, 2016, 15 (04) : 377 - 380
  • [2] Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumours: A randomized phase II study
    Milano, A.
    D'Antonio, C.
    Roberto, M.
    Falcone, R.
    Di Pietro, F. R.
    Durante, V.
    Romiti, A.
    Marchetti, P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S381 - S382
  • [3] Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial
    Roberto, Michela
    Romiti, Adriana
    Mazzuca, Federica
    Milano, Annalisa
    D'Antonio, Chiara
    Lionetto, Luana
    Falcone, Rosa
    Strigari, Lidia
    Simmaco, Maurizio
    Fais, Stefano
    Marchetti, Paolo
    CANCERS, 2020, 12 (11) : 1 - 12
  • [4] Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
    Li, Jian-wei
    Zuo, Wen-jia
    Ivanova, Diana
    Jia, Xiao-qing
    Lei, Li
    Liu, Guang-yu
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (02) : 407 - 415
  • [5] Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
    Jian-wei Li
    Wen-jia Zuo
    Diana Ivanova
    Xiao-qing Jia
    Li Lei
    Guang-yu Liu
    Breast Cancer Research and Treatment, 2019, 173 : 407 - 415
  • [6] Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients -: Results of a phase II study
    Steinbild, Simone
    Arends, Jann
    Medinger, Michael
    Haering, Brigitte
    Frost, Annette
    Drevs, Joachim
    Unger, Clemens
    Strecker, Ralph
    Hennig, Juergen
    Mross, Klaus
    ONKOLOGIE, 2007, 30 (12): : 629 - 635
  • [7] A phase II trial of low-dose metronomic oral vinorelbine as salvage treatment in advanced non-small cell lung cancer (NSCLC)
    Agelaki, S.
    Kontopodis, E. D.
    Kentepozidis, N.
    Giassas, S.
    Vamvakas, L.
    Androulakis, N.
    Kotsakis, K.
    Sfakiotaki, G.
    Mavroudis, D.
    Georgoulias, V
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S448 - S448
  • [8] Oral metronomic chemotherapy using cyclophosphamide in metastatic patients (pts) after standard treatment: Results of a randomized phase II trial
    Clisant, S.
    Adenis, A.
    Dansin, E.
    Desauw, C.
    Degardin, M.
    Mortier, L.
    Fournier, C.
    Penel, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Treatment outcomes in patients with globus: A randomized control trial of psychoeducation, neuromodulators, and proton pump inhibitors
    Poovipirom, Natthanan
    Ratta-apha, Woraphat
    Maneerattanaporn, Monthira
    Geeratragool, Tanawat
    Chuenprapai, Pritsana
    Leelakusolvong, Somchai
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35 (03):
  • [10] A RANDOMIZED CONTROLLED TRIAL OF PROTON PUMP INHIBITORS IN THE TREATMENT OF ACUTE PANCREATITIS PATIENTS: THE BENEFITS AND HARMS
    Ma, Xiao
    Liu, Ling
    Tong, Huan
    Tang, Shihang
    Ye, Cheng
    Tai, Yang
    Tang, Chengwei
    GASTROENTEROLOGY, 2017, 152 (05) : S73 - S73
12345